Evidence map›Paper›PMID 22081021›Full record

ArticleNature medicine2011

Requirement of argininosuccinate lyase for systemic nitric oxide production.

Ayelet Erez, Sandesh C S Nagamani, Oleg A Shchelochkov, Muralidhar H Premkumar, Philippe M Campeau, Yuqing Chen, Harsha K Garg, Li Li, Asad Mian, Terry K Bertin and 12 more

Registry-linked trialAbstract read
In one paragraph

Article in Nature medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03064048 (Effect of Nitric Oxide), which is not on this map. Cited by 124 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed, 1 pooled it
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03064048 nacompletednot on this mapstarted 2017, after this paper: background citation

Effect of Nitric Oxide (NO) Supplementation on Neurocognitive Measures in Argininosuccinate Lyase Deficiency (ASLD)

TypeinterventionalSponsorBaylor College of MedicineRan2017 to 2023Enrolled16ConditionsArgininosuccinate Lyase Deficiency, Urea Cycle Disorder, Urea Cycle Disorders, Inborn, Argininosuccinic AciduriaArmsNeo-ASA, Placebo
3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 1 synthesis or guideline pooled it, 223 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Biomarkers for liver disease in urea cycle disorders.Molecular genetics and metabolism · 2021
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Science advances · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Nitrogen Isotope Effects in Urea Metabolism: From Biochemistry toInternational journal of molecular sciences · 2026
    Review
  14. Article
  15. Predicting epistasis across proteins by structural logic.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 10 institutions in 1 country.

Ayelet ErezDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Sandesh C S Nagamani
Oleg A Shchelochkov
Muralidhar H Premkumar
Philippe M Campeau
Yuqing Chen
Harsha K Garg
Li Li
Asad Mian
Terry K Bertin
Jennifer O Black
Heng Zeng
Yaoping Tang
Anilkumar K Reddy
Marshall Summar
William E O'Brien
David G Harrison
William E Mitch
Juan C Marini
Judy L Aschner
Nathan S Bryan
Brendan Lee
Baylor College of Medicine · USHoward Hughes Medical Institute · USBrown Foundation · USEmory University · USVanderbilt University Medical Center · USCenter for Human Genetics · USHouston Methodist · USTexas Children's Hospital · USThe University of Texas Health Science Center at Houston · USUnited States Department of Agriculture · US

Funding

ZOLENDRONIC ACID IN CHILDREN W/ SEVERE OSTEOGENESIS IMPERFECTAM01RR000188 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI SHEARER, WILLIAM THOMAS · 1985 to 2011
$30.6M
Training (Career Development) ComponentU54HD061221 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI GROPMAN, ANDREA LYNNE · 2009 to 2023
$20.8M
MEDICAL GENETICS RESEARCH FELLOWSHIP PROGRAMT32GM007526 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI Brendan Lee · 1985 to 2026
$11.4M
RARE DISEASES CRC: UREA CYCLE DISORDERSU54RR019453 · NCRR · CHILDREN'S RESEARCH INSTITUTE · PI BATSHAW, MARK L. · 2003 to 2008
$7.0M
PROTEIN NUTRITION IN EXPERIMENTAL UREMIAR01DK037175 · NIDDK · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI Zhaoyong Hu · 1986 to 2026
$4.3M
ULTRASONIC INSTRUMENTATION FOR CARDIOVASCULAR STUDIESR01HL022512 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI HARTLEY, CRAIG J. · 1985 to 2012
$4.3M
PROTEIN NUTRITION IN EXPERIMENTAL UREMIAR37DK037175 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI MITCH, WILLIAM EVANS · 2006 to 2015
$3.8M
Argininosuccinate Lyase is an essential regulator of systemic nitric oxide producR01GM090310 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI LEE, BRENDAN · 2009 to 2013
$1.9M
ENTERAL PRECURSORS FOR UREA SYNTHESIS IN HUMANSR01DK054450 · NIDDK · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI LEE, BRENDAN HL · 1998 to 2006
$1.6M
Hsp90/Client Protein Interactions in the Newborn LungR01HL075511 · NHLBI · VANDERBILT UNIVERSITY · PI ASCHNER, JUDY LYNN · 2005 to 2008
$1.5M
Mouse models for studying citrulline recycling for sustaining NO productionK01RR024173 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI MARINI, JUAN · 2007 to 2011
$614k
SIGNALING &METABOLIC ROLES OF GLUCOSE IN SPERMK01RR000188 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI TRAVIS, ALEXANDER J · 2000 to 2004
$589k
CIHRNCRR NIH HHS K01 RR000188NCRR NIH HHS K01 RR024173NCRR NIH HHS M01 RR000188NCRR NIH HHS RR00188NCRR NIH HHS RR024173NCRR NIH HHS RR19453NCRR NIH HHS U54 RR019453NHLBI NIH HHS HL75511NHLBI NIH HHS R01 HL022512NHLBI NIH HHS R01 HL075511NICHD NIH HHS U54 HD061221NIDDK NIH HHS DK081735NIDDK NIH HHS DK37175NIDDK NIH HHS DK54450NIDDK NIH HHS K08 DK081735NIDDK NIH HHS R01 DK037175NIDDK NIH HHS R01 DK054450NIDDK NIH HHS R37 DK037175NIGMS NIH HHS GM07526NIGMS NIH HHS GM90310NIGMS NIH HHS R01 GM090310NIGMS NIH HHS T32 GM007526
6 · The paper itself

Abstract

Nitric oxide (NO) is crucial in diverse physiological and pathological processes. We show that a hypomorphic mouse model of argininosuccinate lyase (encoded by Asl) deficiency has a distinct phenotype of multiorgan dysfunction and NO deficiency. Loss of Asl in both humans and mice leads to reduced NO synthesis, owing to both decreased endogenous arginine synthesis and an impaired ability to use extracellular arginine for NO production. Administration of nitrite, which can be converted into NO in vivo, rescued the manifestations of NO deficiency in hypomorphic Asl mice, and a nitric oxide synthase (NOS)-independent NO donor restored NO-dependent vascular reactivity in humans with ASL deficiency. Mechanistic studies showed that ASL has a structural function in addition to its catalytic activity, by which it contributes to the formation of a multiprotein complex required for NO production. Our data demonstrate a previously unappreciated role for ASL in NOS function and NO homeostasis. Hence, ASL may serve as a target for manipulating NO production in experimental models, as well as for the treatment of NO-related diseases.

Indexed as

AnimalsArginineArgininosuccinate LyaseArgininosuccinate SynthaseArgininosuccinic AciduriaCell LineDisease Models, AnimalEndothelial CellsFemaleFibroblastsGene Knockdown TechniquesHumansMaleMiceMice, Inbred C57BLMice, KnockoutArginineArgininosuccinate LyaseArgininosuccinate SynthaseNitric OxideNitric Oxide SynthaseNitritesRNA, Small Interfering

Identifiers

PMID22081021
PMCPMC3348956
OpenAlexW2087900616

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.